Birth Cohort Testing for Hepatitis C Virus: Implications for Clinical Social Workers in Health Care Settings

REFERENCES

• Ademmer , K. 2001 . Suicidal ideation with IFN-alpha and ribavirin in a patient with hepatitis C . Psychosomatics , 42 ( 4 ) : 365 – 367 .
   PubMed Web of Science ®Google Scholar
• Afdhal , N.H. 2004 . The natural history of hepatitis C . Seminars in Liver Disease , 24 ( Suppl 2 ) : 3 – 8 . doi: 10.1055/s-2004–832922
   PubMedGoogle Scholar
• American Psychiatric Association , A.P. 2000 . Diagnostic Criteria From DSM-IV-TR , Washington , DC : The American Psychiatric Association .
   Google Scholar
• Armstrong , G. , Wasley , A. , Simard , E. , McQuillan , G. , Kuhnert , W. and Alter , M. 2006 . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 . Annals of Internal Medicine , 144 ( 10 ) : 705 – 714 .
   PubMed Web of Science ®Google Scholar
• Ascione , A. , Tartaglione , T. and Di Costanzo , G. 2007 . Natural history of chronic hepatitis C virus infection . Digestive and Liver Disease , 39 : S4 – S7 . (Suppl 1)
   Google Scholar
• Asnis , G.M. and De La Garza , R. 2006 . Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches . Journal of Clinical Gastroenterology , 40 ( 4 ) : 322 – 335 . doi: 10.1097/01.mcg.0000210099.36500.fe
   PubMed Web of Science ®Google Scholar
• Bacon , B. and McHutchison , J. 2007 . Into the light: Strategies for battling hepatitis C . The American Journal of Managed Care , 13 ( Suppl 1 ) : S319 – S326 .
   PubMedGoogle Scholar
• Bedossa , P. and Poynard , T. 1996 . An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group . Hepatology (Baltimore, MD) , 24 ( 2 ) : 289 – 293 . doi: 10.1002/hep.510240201
   PubMed Web of Science ®Google Scholar
• Biggins , S.W. , Bambha , K.M. , Terrault , N.A. , Inadomi , J. , Shiboski , S. , Dodge , J.L. and … Roberts , J.P. 2012 . Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma . Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society , 18 ( 12 ) : 1471 – 1478 . doi: 10.1002/lt.23551
   PubMed Web of Science ®Google Scholar
• Callendret , B. and Walker , C.M. 2012 . Will there be a vaccine to protect against the hepatitis C virus? . Gastroenterology , 142 ( 6 ) : 1384 – 1387 . doi: 10.1053/j.gastro.2012.02.010
   PubMed Web of Science ®Google Scholar
• Capuron , L. , Gumnick , J.F. , Musselman , D.L. , Lawson , D.H. , Reemsnyder , A. , Nemeroff , C.B. and Miller , A.H. 2002 . Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions . Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology , 26 ( 5 ) : 643 – 652 . doi: 10.1016/S0893-133X(01)00407-9
   PubMed Web of Science ®Google Scholar
• Chen , S.L. and Morgan , T.R. 2006 . The natural history of hepatitis C virus (HCV) infection . International Journal of Medical Sciences , 3 ( 2 ) : 47 – 52 .
   PubMedGoogle Scholar
• Choo , Q.L. , Kuo , G. , Weiner , A.J. , Overby , L.R. , Bradley , D.W. and Houghton , M. 1989 . Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome . Science , 244 ( 4902 ) : 359 – 362 .
   PubMed Web of Science ®Google Scholar
• Crone , C.C. , Gabriel , G.M. and Wise , T.N. 2004 . Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C . Cleveland Clinic Journal of Medicine , 71 ( Suppl 3 ) : S27 – S32 .
   PubMedGoogle Scholar
• Dan , A.A. , Martin , L.M. , Crone , C. , Ong , J.P. , Farmer , D.W. , Wise , T. and … Younossi , Z.M. 2006 . Depression, anemia and health-related quality of life in chronic hepatitis C . Journal of Hepatology , 44 ( 3 ) : 491 – 498 . doi: 10.1016/j.jhep.2005.11.046
   PubMed Web of Science ®Google Scholar
• Dieffenbach , C. and Fauci , A. 2009 . Universal voluntary testing and treatment for prevention of HIV transmission . Journal of the American Medical Association , 301 ( 22 ) : 2380 – 2382 . doi: 10.1001/jama.2009.828
   PubMed Web of Science ®Google Scholar
• Dieperink , E. 2004 . Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C . General Hospital Psychiatry , 26 ( 3 ) : 237 – 240 . doi: 10.1016/j.genhosppsych.2004.01.003
   PubMed Web of Science ®Google Scholar
• Diez Quevedo , C. , Masnou , H. , Planas , R. , Castellvi , P. , Gimenez , D. , Morillas , R. and … Pretel , J. 2011 . Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: A 12-week, randomized, double-blind, placebo-controlled trial . The Journal of Clinical Psychiatry , 72 ( 4 ) : 522 – 528 . doi: 10.4088/JCP.09m05282blu
   PubMed Web of Science ®Google Scholar
• Evon , D.M. , Ramcharran , D. , Belle , S.H. , Terrault , N.A. , Fontana , R.J. and Fried , M.W. 2009 . Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: Results of the Virahep-C study . The American Journal of Gastroenterology , 104 ( 12 ) : 2949 – 58 . doi: 10.1038/ajg.2009.528
   PubMed Web of Science ®Google Scholar
• Feinstone , S.M. , Kapikian , A.Z. , Purcell , R.H. , Alter , H.J. and Holland , P.V. 1975 . Transfusion-associated hepatitis not due to viral hepatitis type A or B . The New England Journal of Medicine , 292 ( 15 ) : 767 – 770 . doi: 10.1056/NEJM197504102921502
   PubMed Web of Science ®Google Scholar
• Fontana , R.J. , Kronfol , Z. , Lindsay , K.L. , Bieliauskas , L.A. , Padmanabhan , L. , Back-Madruga , C. and … Stoddard , A.M. 2008 . Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C . The American Journal of Gastroenterology , 103 ( 11 ) : 2766 – 2775 . doi: 10.1111/j.1572-0241.2008.02106.x
   PubMed Web of Science ®Google Scholar
• Fried , M.W. , Shiffman , M.L. , Reddy , K.R. , Smith , C. , Marinos , G. , Goncales , F.L. Jr and … Yu , J. 2002 . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection . The New England Journal of Medicine , 347 ( 13 ) : 975 – 982 . doi: 10.1056/NEJMoa020047
   PubMed Web of Science ®Google Scholar
• Granich , R. , Gilks , C. , Dye , C. , De Cock , K. and Williams , B. 2009 . Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model . Lancet , 373 ( 9657 ) : 48 – 57 . doi: 10.1016/S0140–6736(08)61697-9
   PubMed Web of Science ®Google Scholar
• Gupta , R.K. , Kumar , R. and Bassett , M. 2006 . Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments . Neuropsychiatric Disease and Treatment , 2 ( 3 ) : 355 – 358 .
   PubMedGoogle Scholar
• Hoofnagle , J.H. and Seeff , L.B. 2006 . Peginterferon and ribavirin for chronic hepatitis C . The New England Journal of Medicine , 355 ( 23 ) : 2444 – 2451 . doi: 10.1056/NEJMct061675
   PubMed Web of Science ®Google Scholar
• Jacobson , I.M. , Pawlotsky , J.M. , Afdhal , N.H. , Dusheiko , G.M. , Forns , X. , Jensen , D.M. and … Schulz , J. 2012 . A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C . Journal of Viral Hepatitis , 19 ( Suppl 2 ) : 1 – 26 . doi: 10.1111/j.1365–2893.2012.01590.x; 10.1111/j.1365–2893.2012.01590.x
   PubMed Web of Science ®Google Scholar
• Klein , M.B. , Cooper , C. , Brouillette , M.J. , Sheehan , N.L. , Benkelfat , C. , Annable , L. and … Singer , L. 2008 . CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy . Contemporary Clinical Trials , 29 ( 4 ) : 617 – 630 . doi: 10.1016/j.cct.2008.01.001
   PubMed Web of Science ®Google Scholar
• Klevens , R.M. , Hu , D.J. , Jiles , R. and Holmberg , S.D. 2012 . Evolving epidemiology of hepatitis C virus in the United States . Clinical Infectious Diseases , 55 ( Suppl 1 ) : S3 – S9 . doi: 10.1093/cid/cis393
   PubMed Web of Science ®Google Scholar
• Kraus , M.R. , Schafer , A. , Al Taie , O. and Scheurlen , M. 2005 . Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression . Journal of Viral Hepatitis , 12 ( 1 ) : 96 – 100 . doi: 10.1111/j.1365–2893.2005.00554.x
   PubMed Web of Science ®Google Scholar
• Kraus , M.R. , Schäfer , A. , Schottker , K. , Keicher , C. , Weissbrich , B. , Hofbauer , I. and Scheurlen , M. 2008 . Therapy of interferon-induced depression in chronic hepatitis C with citalopram: A randomised, double-blind, placebo-controlled study . Gut , 57 ( 4 ) : 531 – 536 . doi: 10.1136/gut.2007.131607
   PubMed Web of Science ®Google Scholar
• Liu , S. , Schneekloth , T. , Talwalkar , J. , Kim , W.R. , Poterucha , J. , Charlton , M. and … Gross , J. 2010 . Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C . Journal of Clinical Gastroenterology , 44 ( 8 ) : e178 – e185 . doi: 10.1097/MCG.0b013e3181dc250f
   Web of Science ®Google Scholar
• Loftis , J.M. and Hauser , P. 2004 . The phenomenology and treatment of interferon-induced depression . Journal of Affective Disorders , 82 ( 2 ) : 175 – 190 . doi: 10.1016/j.jad.2004.04.002
   PubMed Web of Science ®Google Scholar
• Loftis , J.M. , Socherman , R.E. , Howell , C.D. , Whitehead , A.J. , Hill , J.A. , Dominitz , J.A. and Hauser , P. 2004 . Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C . Neuroscience Letters , 365 ( 2 ) : 87 – 91 . doi: 10.1016/j.neulet.2004.04.058
   PubMed Web of Science ®Google Scholar
• Loftis , J.M. , Patterson , A.L. , Wilhelm , C.J. , McNett , H. , Morasco , B.J. , Huckans , M. and … Hauser , P. 2013 . Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: A 16-week prospective study . Journal of Psychosomatic Research , 74 ( 1 ) : 57 – 63 . doi: 10.1016/j.jpsychores.2012.10.012
   PubMed Web of Science ®Google Scholar
• McGarry , L. , Pawar , V. , Panchmatia , H. , Rubin , J. , Davis , G. , Younossi , Z. and … Weinstein , M. 2012 . Economic model of a birth cohort screening program for hepatitis C virus . Hepatology , 55 ( 5 ) : 1344 – 1355 . doi: 10.1002/hep.25510
   PubMed Web of Science ®Google Scholar
• Mistler , L.A. , Brunette , M.F. , Marsh , B.J. , Vidaver , R.M. , Luckoor , R. and Rosenberg , S.D. 2006 . Hepatitis C treatment for people with severe mental illness . Psychosomatics , 47 ( 2 ) : 93 – 107 . doi: 10.1176/appi.psy.47.2.93
   PubMed Web of Science ®Google Scholar
• Morasco , B.J. , Loftis , J.M. , Indest , D.W. , Ruimy , S. , Davison , J.W. , Felker , B. and Hauser , P. 2010 . Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: A double-blind, placebo-controlled trial . Psychosomatics , 51 ( 5 ) : 401 – 408 . doi: 10.1176/appi.psy.51.5.401
   PubMed Web of Science ®Google Scholar
• Myint , A.M. , Schwarz , M.J. , Steinbusch , H.W. and Leonard , B.E. 2009 . Neuropsychiatric disorders related to interferon and interleukins treatment . Metabolic Brain Disease , 24 ( 1 ) : 55 – 68 . doi: 10.1007/s11011-008-9114-5
   PubMed Web of Science ®Google Scholar
• Neri , S. , Bertino , G. , Petralia , A. , Giancarlo , C. , Rizzotto , A. , Calvagno , G.S. and … Palermo , F. 2010 . A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin . Journal of Clinical Gastroenterology , 44 ( 9 ) : e210 – e217 . doi: 10.1097/MCG.0b013e3181d88af5
   Web of Science ®Google Scholar
• Pearlman , B. and Traub , N. 2011 . Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: A cure and so much more . Clinical Infectious Diseases , 52 ( 7 ) : 889 – 900 . doi: 10.1093/cid/cir076
   PubMed Web of Science ®Google Scholar
• Quelhas , R. and Lopes , A. 2009 . Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: A review . Journal of Psychiatric Practice , 15 ( 4 ) : 262 – 281 . doi: 10.1097/01.pra.0000358313.06858.ea
   PubMedGoogle Scholar
• Raison , C.L. , Demetrashvili , M. , Capuron , L. and Miller , A.H. 2005a . Neuropsychiatric adverse effects of interferon-alpha: Recognition and management . CNS Drugs , 19 ( 2 ) : 105 – 123 .
   PubMed Web of Science ®Google Scholar
• Raison , C.L. , Broadwell , S.D. , Borisov , A.S. , Manatunga , A.K. , Capuron , L. , Woolwine , B.J. and … Miller , A.H. 2005b . Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C . Brain, Behavior, and Immunity , 19 ( 1 ) : 23 – 27 . doi: 10.1016/j.bbi.2004.05.001
   PubMed Web of Science ®Google Scholar
• Raison , C.L. , Woolwine , B.J. , Demetrashvili , M.F. , Borisov , A.S. , Weinreib , R. , Staab , J.P. and … Miller , A.H. 2007 . Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C . Alimentary Pharmacology & Therapeutics , 25 ( 10 ) : 1163 – 1174 . doi: 10.1111/j.1365–2036.2007.03316.x
   PubMed Web of Science ®Google Scholar
• Ravera , G. , Bottaro , L.C. , Franceschini , M. , Morando , A. , De Polo , M. , Zare , M. and … Zanardi , S. 2006 . Reliability and diagnostic use of a test for the search of the hepatitis C virus Ag (AgHCV) . Hepato-Gastroenterology , 53 ( 71 ) : 753 – 756 .
   PubMed Web of Science ®Google Scholar
• Rein , D. , Smith , B. , Wittenborn , J. , Lesesne , S. , Wagner , L. , Roblin , D. and … Weinbaum , C. 2012 . The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings . Annals of Internal Medicine , 156 ( 4 ) : 263 – 270 . doi: 10.1059/0003–4819–156–4–201202210–00378
   PubMed Web of Science ®Google Scholar
• Rein , D.B. , Wittenborn , J.S. , Weinbaum , C.M. , Sabin , M. , Smith , B.D. and Lesesne , S.B. 2011 . Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States . Digestive and Liver Disease□: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver , 43 ( 1 ) : 66 – 72 . doi: 10.1016/j.dld.2010.05.006
   Google Scholar
• Robaeys , G. , Wichers , M.C. , De Bie , J. , Koek , G.H. , Buntinx , F. and Van Os , J. 2009 . Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy? . Gut , 58 ( 1 ) : 145 – 146 . 145; author reply doi: 10.1136/gut.2008.156919
   PubMed Web of Science ®Google Scholar
• Rustgi , V.K. 2007 . The epidemiology of hepatitis C infection in the United States . Journal of Gastroenterology , 42 ( 7 ) : 513 – 521 . doi: 10.1007/s00535-007-2064-6
   PubMed Web of Science ®Google Scholar
• Saunders , J.C. 2008 . Neuropsychiatric symptoms of hepatitis C . Issues in Mental Health Nursing , 29 ( 3 ) : 209 – 220 . doi: 10.1080/01612840701869239
   PubMedGoogle Scholar
• Schäfer , A. , Scheurlen , M. , Seufert , J. , Keicher , C. , Weissbrich , B. , Rieger , P. and Kraus , M.R. 2010 . Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression . Journal of Hepatology , 52 ( 1 ) : 10 – 5 . doi: 10.1016/j.jhep.2009.10.007
   PubMedGoogle Scholar
• Sheafor , B.W. and Horejsi , C.R. 2012 . Techniques and Guidelines for Social Work Practice , 9th , Boston , MA : Allyn & Bacon .
   Google Scholar
• Sherman , K.E. , Flamm , S.L. , Afdhal , N.H. , Nelson , D.R. , Sulkowski , M.S. , Everson , G.T. and … Poordad , F. 2011 . Response-guided telaprevir combination treatment for hepatitis C virus infection . The New England Journal of Medicine , 365 ( 11 ) : 1014 – 1024 . doi: 10.1056/NEJMoa1014463
   PubMed Web of Science ®Google Scholar
• Smith , B. , Morgan , R. , Beckett , G. , Falck-Ytter , Y. , Holtzman , D. and Ward , J. 2012 . “ Hepatitis C virus testing of persons born during 1945 to 1965: Recommendations from the Centers for Disease Control and Prevention ” . In Annals of Internal Medicine doi: 10.7326/0003–4819–157–9–201211060–00529
   Google Scholar
• Smith , K.J. , Norris , S. , O'Farrelly , C. and O'Mara , S.M. 2011 . Risk factors for the development of depression in patients with hepatitis C taking interferon-alpha . Neuropsychiatric Disease and Treatment , 7 : 275 – 292 . doi: 10.2147/NDT.S13917
   PubMed Web of Science ®Google Scholar
• Sockalingam , S. and Abbey , S. 2009 . Managing depression during hepatitis C treatment . Canadian Journal of Psychiatry , 54 ( 9 ) : 614 – 625 .
   PubMed Web of Science ®Google Scholar
• Swain , M.G. , Lai , M.-Y. , Shiffman , M.L. , Cooksley , W.G.E. , Zeuzem , S. , Dieterich , D.T. and … Diago , M. 2010 . A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin . Gastroenterology , 139 ( 5 ) : 1593 – 601 . doi: 10.1053/j.gastro.2010.07.009
   PubMed Web of Science ®Google Scholar
• Ward , J.W. 2013 . The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States . Clinics in Liver Disease , 17 ( 1 ) : 1 – 11 . doi: 10.1016/j.cld.2012.09.011
   PubMed Web of Science ®Google Scholar
• Wise , T. 2011 . Prophylactic citalopram treatment in hepatitis C patients on antiviral therapy: Will it limit drug-induced depression and enhance adherence? . Current Psychiatry Reports , 13 ( 1 ) : 1 – 2 . doi: 10.1007/s11920-010-0161-3
   PubMedGoogle Scholar
• Yee , H.S. , Chang , M.F. , Pocha , C. , Lim , J. , Ross , D. , Morgan , T.R. and … National Hepatitus C Program Office . 2012 . Update on the management and treatment of hepatitis C virus infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office . The American Journal of Gastroenterology , 107 ( 5 ) : 669 – 689 . quiz 690 doi: 10.1038/ajg.2012.48
   PubMed Web of Science ®Google Scholar